Omnia Biologics has sealed a deal to help the Aeras Global TB
Vaccine Foundation in its quest to make quantities of a new TB
Vaccine that will "fulfil all the needs of the developing
world."
Israeli biopharma firm Kamada will manufacture transferrin for an
undisclosed European pharma firm embarking on the first ever
clinical trials of a drug that includes the substance.
Chugai Pharmaceutical has decided to manufacture a modified version
of Roche's Tamiflu (oseltamivir) in a dry syrup formulation which
can be stored at room temperature after the bottle is opened,
allowing for more storage capacity...
A new white paper has been made available to laboratories
worldwide, which aims to minimise the risk of infection through
focused biosafety reviews and further reinforce the required level
of infection control.
A new concept to develop a more accurate method for rapidly
screening chemical compounds has been unveiled, which the
researchers say will significantly aid in identifying leads for
drug development and discovery.
The US Food and Drug Administration (FDA) has outlined a series of
imminent changes to the way it evaluates clinical trials in an
attempt to clamp down on fraud.
The pharmaceutical and life sciences industries are flushed with
quality IT services, with eight companies that have a specialist
life science/pharmaceutical focus being featured in the top 20 of
the first-ever listing of the world's...
Rentschler Biotechnologie has heralded the start of a €50m
expansion to increase its capacity to produce antibodies and
mammalian cell culture-derived proteins on a commercial scale.
Pfizer has issued another recall for packs of its blockbuster
cholesterol drug Lipitor after UK regulators found evidence of more
counterfeit product in the legitimate supply chain from a batch
whose withdrawal was supposed to have...
Researchers in the US have developed an exciting new tool that
enables scientists to watch cell chemical activity in real-time.
The tool's development has major implications for speeding up new
drug design.
MedImmune and Micromet have provided details on a novel drug
molecule that targets a tyrosine kinase receptor that is frequently
overexpressed on solid tumours and provides the opportunity to
develop an anti-cancer therapeutic, which...
Alnylam has been issued a US patent, which protects its method of
making small interfering RNAs with and without chemical
modifications, which is set to have far reaching implications in
future drug discovery.
According to the results of a new survey HIV patients are in the
dark about treatment options and the significance of drug
resistance, not only jeopardising their own health but also
potentially exacerbating the problem of limited...
A team of scientists believe that a worm can help to discover new
drugs by genetically modification allowing the worm to distinguish
harmful chemicals to those with therapeutic benefit.
Irish pharmaceutical specialist Guy & Co has been strengthened
by the recent acquisition of leading US-based pharmaceutical
packaging specialist Pharmagraphics according to its parent company
and will now be known as Pharmagraphics...
Specialty chemicals firm Cognis has received good manufacturing
practice (GMP) certification for its production of pharmaceutical
excipients in Germany, the first chemical company in the world to
do so but certainly not the last.
As it consolidates its manufacturing operations in the US, Watson
Pharmaceuticals has received a warning letter from the US Food and
Drug Administration (FDA) accusing it of using the wrong
ingredients in the production of capsules,...
Outourcing-Pharma focus on: FDA clinical trial initiatives
The US Food and Drug Administration (FDA) has signalled it will
soon allow a new "adaptive" approach to clinical trials in order to
streamline drug testing and speed drugs to market.
After a ruthless battle between US states, Novartis has selected
Holly Springs in North Carolina for its vaccine manufacturing plant
which will use novel cell culture technology to dramatically speed
up production - the first facility...
Momentum is growing at the UK's new National Biomanufacturing
Centre (NBC) as its operator Eden Biodesign inked a second contract
at the centre - set up to establish England's Northwest as one of
the top biomanufacturing...
European researchers have not only devised a new diagnostic lab
tool for prostate cancer but have also identified a new molecular
marker that makes the identification of the disease much quicker.
The Japanese pharmaceutical industry is eyeing India as a new hub
to conduct its contract manufacturing and clinical trials - India
is thirsty for new Japanese investment.
Agilent Technologies has introduced its new microarray that offers
high-resolution genomic coverage, whilst enabling multiple
experiments per slide. The technology has the potential to make
savings both in time and cost.
Galapagos and Cellzome have announced the start of a drug discovery
collaboration in which the two companies are to concentrate on
kinases, a popular target for pharmaceutical therapies for cancer
and inflammatory diseases.
With its manufacturing practices in Puerto Rico censured and
marketing approval of its new oral contraceptive delayed because of
its packaging, Wyeth has announced a plan to address its
manufacturing issues but cautions there is no...
According to a new report the proteomic revolution and the
emergence of the customised drug market has led to an increased
demand for mass spectrometers in the US, driving strong growth over
the next seven years.
Labelling and packaging equipment company Advanced Dynamics has
unveiled a new machine to label the outer packaging of
pharmaceutical products in Braille, allowing companies to comply
with EU regulations.
Indian custom chemical synthesis firm Denisco has opened up shop in
the US to capitalise on the growing demand in North America for
high-quality, low-cost complex organic molecules.
The US Food and Drug Administration (FDA) has turned down Nastech's
generic version of the nasal spray Miacalcin for the treatment of
osteoporosis because of the possibility of an interaction with a
preservative used in the formulation,...
There's welcome relief for haemorrhoid sufferers after researchers
identified the existence of an enzyme that could be key to treating
chronic and severe disorders such as certain forms of constipation,
anal fissures and Hirschsprung's...
A unique approach to drug development could be on the horizon after
researchers utilised a method to crystallise proteins that would
allow better examination of proteins, leading to the production of
targeted drugs.
Biotechnology firm Alexion has acquired a Dow biomanufacturing
facility in Rhode Island as it gears up for the commercialisation
of its blood disorder drug Soliris, yet the move does not signal
the end of the company's contract...
Bio-Rad Labs and Integrated DNA Technologies (IDT), have announced
a collaboration to develop RNA interference (RNAi) tools sets for
life science researchers.
In an incident Roxane Laboratories warns could have
life-threatening consequences, a manufacturing lot of azathioprine
tablets has been recalled in the US and Puerto Rico following the
discovery of methotrexate tablets in one of its...
Sales, sales, sales has been the focus of drug manufacturers so far
this year, while interest continues to remain high on the topics of
India and generics.
Despite looming threats from cheap Asian competitors, European
contract research organisations (CROs) still have a fighting chance
in the global R&D outsourcing market, according to a report by
research analysts Frost & Sullivan.
Looking to expand its laboratory testing and consulting services,
PharmEng has acquired Rootlink Tecknic, a laboratory
instrumentation automated solution sales and service company based
in Toronto.
Archemix has announced the formation of a strategic alliance with
Elan to discover and develop first-in-class aptamer therapeutics to
treat autoimmune disease.
AstraZeneca will be using Werum's PAS-X system at its two German
production sites to collect operating data from its packaging lines
and define and evaluate key performance indicators (KPI), improving
equipment performance.
Neuropharma has developed a new treatment for Alzheimer's Disease,
which uses a unique method of attack, incorporating a mechanism of
action that targets a little-known enzyme that contributes to the
proliferation of the neurodegenerative...
Biopharmaceutical firm Nektar has agreed to fork out $25m (€20m) to
settle a patent lawsuit by the University of Alabama in Huntsville
(UAH) concerning the company's PEGylation delivery technology
currently used in eight approved...
US scientists have discovered that sugar and olive oil do not just
belong in the kitchen - but could potentially be used to develop
naturally-derived nanomaterials for drug delivery systems and
biological scaffolds.
GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...
Torey Pines Scientific has announced the launch if its new stirring
hot plate, which has been designed for use in the chemical,
pharmaceutical, biochemical, and laboratories where reproducible,
accurate, hands-off sample preparation...
Companies in the healthcare sector, including drug discovery
technologies, healthcare and life sciences IT, and medical devices
were out in force this week at Frost & Sullivan's 2006
Excellence in Healthcare Awards
Ohaus make available its new series of semi-micro and analytical
balances specifically designed for applications that require
precise measurement in the pharmaceutical research, drug discovery,
and general lab application arena.
